Creative Proteomics provides a high-quality and high-sensitivity analysis to detect and quantify HCPs by mass spectrometry (MS), in accordance with relevant guidelines (ICH Q6B, PharmEu and USP). The HCP coverage of generic or process-specific Enzyme Linked Immunosorbent Assay (ELISA) polyclonal antibodies can also be validated. Our professional scientists and analysts will deploy optimal approaches to fully detect, characterize, and quantify HCPs in the biopharmaceutical products, and meet requirements of each stage of drug discovery.
Latvijaskazinobonus
Tip88
Sôclive - Soclive Tv
Emilia Riley
Local News In Florence
Uu666
Ts Group
Snatch Anmeldung
Ar Shopfronts
Newvibe Remodel Llc